1-4 of 4
Junjiang Sun, MD
Close
Sort by
Journal Articles

The Effect of Prophylactic Recombinant Factor IX and Glycopegylated Factor IX to Normalize Articular Wound Healing Following Hemarthrosis Examined in Hemophilia B Mice

Junjiang Sun, MD, Eric Livingston, Tom Knudsen, DVM, PhD, Dougald M. Monroe, III, PhD, Mirella Ezban, PhD, Ted Bateman, PhD, Paul E. Monahan, MD
Journal: Blood
Blood (2015) 126 (23): 549.
https://doi.org/10.1182/blood.V126.23.549.549
Published: 2015
Journal Articles

Employing Factor IX Variants to Avoid Limitations Imposed by Immune Recognition of AAV Vector in Hemophilia B Gene Therapy

Paul E. Monahan, MD, Junjiang Sun, MD, Tong Gui, PhD, David G Wichlan, Scott W McPhee, R. Jude Samulski
Journal: Blood
Blood (2011) 118 (21): 3124.
https://doi.org/10.1182/blood.V118.21.3124.3124
Published: 2011
Journal Articles

Hemophilia B Mouse Lines Doubly Humanized for Human F9 and MHC Class II Genes Advance Specificity of Inhibitor Study

Genlin Hu, PhD, Tong Gui, PhD, Junjiang Sun, MD, Darrel W. Stafford, PhD, R. Jude Samulski, PhD, Paul E. Monahan, MD
Journal: Blood
Blood (2011) 118 (21): 200.
https://doi.org/10.1182/blood.V118.21.200.200
Published: 2011
Journal Articles

Extravascular Clotting Factor Activity within Joint Tissues Protects Against Progression of Hemophilic Arthropathy.

Junjiang Sun, MD, Narine Hakobyan, PhD, Leonard A. Valentino, MD, Paul E. Monahan, MD
Journal: Blood
Blood (2007) 110 (11): 496.
https://doi.org/10.1182/blood.V110.11.496.496
Published: 2007